| Literature DB >> 34307427 |
Alejandra Ramírez-Venegas1, Francisco Montiel-Lopez1, Ramces Falfan-Valencia2, Gloria Pérez-Rubio2, Raúl H Sansores3.
Abstract
Although different trajectories in lung function decline have been identified in patients with COPD associated to tobacco exposure (TE-COPD), genetic, environmental, and infectious factors affecting lung function throughout life have not been fully elucidated in patients with COPD associated to biomass (BE-COPD). In this review, we present current epidemiological findings and notable advances in the natural history of lung decline in BE-COPD, as well as conditions modeling the FEV1 trajectory, such as health insults, during the first years of childhood. Evidence shows that women exposed to biomass smoke reach adult life with a lower FEV1 than expected. However, in contrast to the "horse racing effect" predicting an excessive lung-function decline in forthcoming years, as observed in smokers, this decline is slower in non-smokers, and no rapid decliners are observed. Accordingly, BE-COPD might be considered another phenotype of COPD based on assessments of lung function decline. Likewise, other functional and clinical aspects described in this review suggest that this condition might be similar to TE-COPD. More research is needed to fully characterize this subgroup of variants of COPD.Entities:
Keywords: COPD; biomass exposure; early life disadvantages factors; lung function decline; non-smokers; slow horse racing effect; tobacco exposure
Year: 2021 PMID: 34307427 PMCID: PMC8295605 DOI: 10.3389/fmed.2021.700836
Source DB: PubMed Journal: Front Med (Lausanne) ISSN: 2296-858X
Figure 1This figure exposes three different trajectories of lung function. Trajectory 1 () shows a group of healthy individuals with no history of insults during childhood nor through all of them life, who had a normal maximal lung function age of 25 and had a normal decline in lung function. Trajectory 2 () shows a group of women who had history of exposure to biomass smoke both in the prenatal and childhood phases, with adverse event during childhood, who had: (a) a reduced maximal lung function (around 80% of predicted) and showing a slow decline after the plateau but with similar trajectory as a normal group. Trajectory 3 () shows the cohort of individual who became smokers at the adolescence, they shape a similar curve as healthy individuals reaching a normal maximal lung function. However, after plateau an accelerated decline is observed.
Figure 2FEV1 decline over time in BE-COPD group () and TE-COPD () group. The Y axis shows annual change of FEV1 as percent of predicted (%/p), whereas X axis shows FEV1 decline through 15 years of follow up. In BE- COPD group the FEV1 starts at higher values (%/p) than TE-COPD group. In order to compare the decline between groups we also show absolute values (ml/year). The annual decline in absolute values in TE-COPD group is two-fold faster than BE-COPD (42 vs. 23 ml/year).
Figure 3This figure shows the contrast of the lung function decline according to the prevalent phenotype. Rapid decliners phenotype: lung function decline >60 ml/year; slow decliners phenotype: lung function decline 30 to 60 ml/year; sustained decliners phenotype: lung function decline 30 ml/year up to 20 ml/year. Proportion of rapid decliners is higher in TE-COPD in comparison to BE-COPD group who have the largest group of sustained decliners and less proportion of slow decliners.
COPD characteristics of subjects exposed to biomass and tobacco smoke.
| Age of awareness of respiratory symptoms | >65 years old | 50–60 years old | ( |
| Wheezing | ++ | + | |
| Phlegm | ++ | + | |
| Chronic bronchitis | ++ | + | ( |
| Dyspnea | +++ | +++/++ | ( |
| Affection of quality of life | +++ | +++/++ | ( |
| Exacerbation frequency | Similar as tobacco (++) | Similar as biomass (++) | ( |
| Walking distance (6 MWD) | Similar as smokers | Similar as biomass | ( |
| Hypoxemia | ++ | + | |
| SpO2 at rest | Lower than tobacco (++) | Low (+) | ( |
| Airflow obstruction | Mild to moderate | Moderate to Severe | ( |
| DLco | Normal | Low | ( |
| Bronchial Hyperresponsiveness | ++ | + | ( |
| Annual lung function decline | Sustained decline/non-faster decline | Less sustained than biomass | ( |
| Small airway resistances | Extremely affected | Affected | ( |
| Computed tomography findings | Airway thickening | Emphysema predominant. | ( |
| Pathology pattern | More anthracosis, | More emphysema | ( |
| Unadjusted by lung function | Better than tobacco | Worse than biomass | ( |
| Adjusted by lung function | Similar as tobacco | Similar as biomass | |
+++, more frequent or more affected; ++, very common; +, common.
Measured with different instruments. 6 MWD, 6-min walking distance; PaO.